| Bristol-Myers Squibb is confident in the safety of our products. We maintain stringent standards at all our manufacturing sites to ensure the high quality and safety of our products that customers have come to expect from us.
The Consumer Product Safety Improvement Act of 2008 requires manufacturers to provide additional information on the child resistant packaging of certain pharmaceuticals sold in the United States. In addition, manufacturers must obtain certification from an independent, accredited laboratory to establish that certain children’s toys and other products meet the necessary safety standards. Products for the purpose of laboratory testing, clinical testing, trade shows, samples or exports are excluded from the new requirements.
More information about the details of this new law
and its implementation may be found on the U.S.
Consumer Product Safety Commission website.
As a next-generation BioPharma leader, Bristol-Myers Squibb pledges to continue to ensure the safety of our products as we work to extend and improve human life through discovering and developing new medicines for unmet medical needs. We encourage our distributors and retailers to verify our certification of the safety of the packaging of our products by entering the product’s national drug code and lot number into the form below.
We follow the applicable requirements of the Poison Prevention
Packaging Act—the law that requires certain products to have child-resistant packaging.
For more information on our product safety certification process, please contact us at 800-332-2056.
Directions to use form:
To locate the appropriate safety certificate, customers may enter the product’s 10-digit national drug code and lot number in the appropriate boxes below.
|
